Back to results
US 2017/0246274 A1Published application
Immunogenic polypeptide cocktail for the treatment of medullary thyroid carcinoma
AssigneeTimothy Andrew Erickson
InventorTimothy Andrew Erickson
Life of this patent
Estimating the term…
Abstract
Disclosed are immunogenic compositions that include one or more polypeptides that, when administered to a subject with adjuvant, elicit an immune response against medullary thyroid cancer. Disclosed are methods of eliciting an immune response and/or treating cancer, such as medullary thyroid carcinoma or other thyroid carcinomas.
Claims18
An immunogenic composition, comprising:
- one or more polypeptides that, when administered to a subject, elicits an immune response to one or more epitopes of a RET polypeptide, a calcitonin polypeptide, a thyroglobulin polypeptide, a thyroid peroxidase (TPO) polypeptide, a HLA-G polypeptide, or a mutant form thereof.
Dependencies are inferred from the claim text.